The benefits of collecting EEG neuroimaging insights in clinical trials.
In clinical trials, brain monitoring EEG is facilitating the measurement of complex clinical endpoints. EEG as a biomarker provides safe, objective and repeatable data enabling a deeper understanding of the pharmacological effects of the drug early in its development.
Happy Holidays from myBrain Tech 🎄 | December 2022.
During this year of 2022, we have dedicated ourselves to make our solution more complete and ergonomic through many updates designed to optimize the way you realize your experiments. The end of the year is for us the opportunity to come back on the major improvements of our solution ...
A milestone for NeuroEthic 📜 | November 2022.
The end of 2022 marks a major step forward in the neurotechnology sector in France: the presentation of a Charter for a responsible development of neurotechnologies by the Ministry of Higher Education and Research. Directly concerned, myBrain Technologies wanted to participate ...
A milestone for NeuroEthics.
The capacity of neurotechnologies to probe and interfere with brain activity challenges notions of identity, integrity and autonomy of human being. Recent initiatives aim to help actors in the field anticipate and address ethical, legal and social challenges, while promoting innovation in this area.
Fusion of VRxEEG for driver modeling 🚗 | October 2022.
To travel miles in full peace of mind, in a car that understands and anticipates every need of the driver on the road, is becoming a reality! With its SaaS neuromarker platform and its new VRxEEG headset, myBrain Technologies makes it possible to create more robust AIs for cars ...
Key industry events to meet your demands 🗝 | September 2022.
myBrain Technologies is committed to provide the most accurate offer possible to support its customers in the development of their products. With the will to enrich its platform of neuromarkers, our team is aware that a knowledge of the needs and sectors in question is the key to a value proposition ...
Say hello to our new statistic tools 🚀 | Summer 2022.
Statistics are here! Discover now our new statistic tools in Analytics to easily interpret your protocol results. Easily navigate, clearly see and quickly determine the effects of your products on your subjects to optimize your decision making ...
What future for AI in Europe? 🤖 | June 2022.
As a company that has developed a solution based on Artificial Intelligence (AI) and neuroscience ans as manufacturer of Medical Devices (MD), myBrain Technologies has to stay up to date with regulations and standards in these fields. For this, we can rely on our quality team! ...
[DOWNLOAD] Artificial Intelligence Act: What future for AI in Europe?
With the increasing evolution of computing, robotics, and new technologies, AI is now a major part of our daily life. On April 21, 2021, the European Commission published a proposed regulation on Artificial Intelligence (AI), the Artificial Intelligence Act, which aims to establish safe and harmonized rules for this innovative field.
myBrain Technologies’s eye on Medical Device Regulation.
In order to improve health safety and harmonize rules within the EU, the Medical Device Regulation has been profoundly revised, resulting in new regulatory requirements - effective from May 26, 2021. To understand the difficulties of its application by manufacturers and find solutions, we interviewed Sophie Colliot.
